Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new study analyzing 82 movies with cancer storylines found that characters' chances of survival were often misrepresented. Researchers suggest that Hollywood films should tackle the realities of cancer diagnosis and treatment to raise awareness among patients and healthcare professionals.
Researchers found that high viral load and cancer-specific viral gene expression are key markers for identifying HPV-driven tumors. These findings suggest that HPV DNA positivity alone is a poor predictor of outcome in head and neck cancers.
A large Taiwanese study of 35,871 patients with newly diagnosed shingles found no increased risk of cancer. The study suggests that enhanced surveillance for cancer after a shingles diagnosis is unnecessary, according to the authors.
Professor Ming Su at UCF's NanoScience Technology Center has been awarded a $2 million NIH New Innovator Award to use nanoparticles to improve radiation therapy. The goal is to reduce damage to surrounding healthy cells while killing cancerous tumors.
A new study found that smokers with lung cancer have 10 times more genetic mutations than those who have never smoked. The researchers identified over 3,700 mutations across all patients and found at least one mutated gene in each non-smoking patient that can be targeted with existing drugs.
Young adults with advanced cancer experience life disruption and losses, affecting their educational, career, and personal goals. Clinical interventions can help patients cope with grief associated with cancer-related losses and life transition.
Researchers at Moffitt Cancer Center found that racial disparities impact the likelihood of finding suitable stem cell donors for non-Caucasian patients. The study revealed greater difficulty in matching donors for African-Americans, Hispanics, and Native Americans, with limited access to unrelated donor HCT.
The 2012 Breast Cancer Symposium presents four major studies on the treatment of early breast cancer, confirming which patient populations benefit from screening interventions and surgical procedures. The research aims to improve treatment decisions and maximize benefits for patients.
Studies find extended office hours reduce health expenditures and improve breast cancer outcomes for Medicare beneficiaries. Additionally, research on adult cancer survivors reveals the need for primary care engagement in follow-up care, while a team-based model of primary care offers potential solutions to excessive patient panel sizes.
A study of 168 Stage III NSCLC patients found that married women had the best three-year survival rate of 46 percent, while single men had the worst rate of 3 percent. Married patients generally had improved survival rates compared to single patients, with 33 percent vs. 10 percent.
A recent study published in the University of Maryland Medical Center found that married lung cancer patients have a higher survival rate compared to single patients. The researchers believe that social support from spouses is a key factor contributing to improved survival rates for married lung cancer patients.
A study published in Cancer Discovery reveals PARP1 and EZH2 as potential therapeutic targets for small cell lung cancer. The discovery could lead to the development of targeted treatments for this aggressive type of cancer, which currently has limited treatment options.
Researchers identified a specific HIF2α mutation in tumor cells of patients with rare cancers, offering clues about cancer cell metabolism. The finding may lead to new targets for cancer treatment development and improve understanding of the mechanisms behind the Warburg effect.
Stephen Byers, a Georgetown Lombardi Comprehensive Cancer Center professor, has been awarded a $2.5 million NCI grant to investigate how certain drugs may prevent cancer. The research aims to understand the mechanism of action of anti-inflammatory drugs that have shown promise in preventing cancer and rheumatoid arthritis.
Researchers analyzed data from 29,423 adult patients and found no statistically significant increased risk of any type of cancer in those treated with biologic response modifiers. This study provides reassuring information for patients considering these therapies for their disease.
Researchers have found a significant association between sleep apnea and an increased risk of cancer mortality. Severe sleep apnea was linked to double the relative risk of death due to cancer in patients who spent more than 14% of their sleep with low oxygen levels.
A meta-analysis of over 60 randomized controlled trials found no statistically significant increased risk of any type of cancer with biologic response modifiers in patients with rheumatoid arthritis. The study included 29,423 patients and followed them for at least 24 weeks.
A new Johns Hopkins study shows that a triple-threat approach to central line care can reduce life-threatening infections in pediatric cancer patients. By deploying strict device-handling precautions and involving families in oversight, the researchers were able to prevent one in five infections over two years.
A study published in Archives of Neurology found an association between Parkinson disease and an increased risk of prostate cancer and melanoma in patients with PD and their relatives. The research used a Utah genealogic database and a statewide cancer registry to examine the relationship between the two diseases.
Researchers at Ohio State University Comprehensive Cancer Center have discovered how tamoxifen-resistant breast-cancer cells grow and proliferate. They suggest an experimental agent might offer a novel targeted therapy for these resistant tumors.
A study published in the Journal of Thoracic Oncology found that patients with low thymidylate synthase (TS) levels and high fibroblast growth factor stimulator (FPGS) levels respond better to pemetrexed treatment. This combination predicts longer survival durations.
A Mayo Clinic study found that exercise can reduce cancer recurrence by up to 50 percent in breast and colon cancer patients. However, many patients are reluctant to exercise due to lack of awareness about its benefits.
A study published in European Journal of Epidemiology found that cancer survival rates in Germany have aligned significantly since reunification. While there are still slight differences, they have decreased compared to the pre-reunification era.
Pediatric cancer patients who underwent total body irradiation (TBI) before age 3 are at risk of developing endocrine, metabolic, and other complications. The study found that 90% showed abnormally low levels of growth hormone and 71% were under height.
Researchers have identified molecular markers that can predict the progression of low-grade oral premalignant lesions to cancer. These markers, including loss of heterozygosity, help clinicians determine which patients are at high risk for progression and need closer follow-up.
A study found that high mammographic breast density, a strong breast cancer risk factor, does not influence survival rates in breast cancer patients. However, low density was associated with increased risk of death among obese patients or those diagnosed with large tumors.
Researchers have validated a radiosensitivity molecular signature that can predict clinical outcomes in patients treated with radiation therapy for breast cancer. The technology, called RSI, identifies radiosensitivity and radioresistance, opening the door to biologically guided radiation therapy.
A phase III study published in Clinical Cancer Research found that denosumab reduced skeletal-related events by 31% compared to zoledronic acid, while also maintaining health-related quality of life. Treatment with denosumab also showed fewer acute reactions and adverse events.
A blood test detecting high levels of lactate dehydrogenase (LDH) may guide treatment for advanced kidney cancer, extending survival and improving outcomes for patients. Researchers found that LDH levels can predict the effectiveness of mTOR inhibitor temsirolimus in treating late-stage kidney cancer.
A new study has found that patients taking thiazolidinedione (TZD) diabetes drugs are two to three times more likely to develop bladder cancer than those who took sulfonylurea drugs. The risk is especially high among Type 2 diabetes patients, with 170 expected cases per 100,000 treated with TZDs.
A recent study found that 86% of non-smokers and 57% of smokers supported the ban, with many smokers expressing interest in quitting. Despite high demand for cessation services, only a few employees took advantage of them.
Cancer cells respond differently to therapy based on their microenvironment, with fibroblasts sustaining DNA damage that promotes growth and resistance. The discovery could lead to more effective treatments by targeting the tumor microenvironment.
Researchers from Netherlands will investigate using DNA analysis to guide personalized cancer treatment, focusing on breast and colorectal tumors. The grant aims to improve patient outcomes by matching patients with the most effective treatments.
A study found that stage IV cancer patients on Medicare are more likely to undergo high-cost diagnostic imaging procedures, which may be driven by the increasing number of treatment options available. The use of imaging has steadily increased between 1995 and 2006, with costs rising faster than overall cancer care costs.
Researchers found that breast cancer patients lacking the retinoblastoma tumor suppressor gene (RB) had a better pathological response to neoadjuvant chemotherapy. A prospective clinical trial has been initiated at the Kimmel Cancer Center to explore this finding further.
Scientists investigate the use of novel AKT inhibitor MK-2206 in combination with erlotinib as a second-line defense for patients with non-small cell lung cancer (NSCLC) who have developed resistance to erlotinib. A Phase II trial has shown promising initial results.
Researchers at John Theurer Cancer Center found carfilzomib to be clinically significant in responding heavily-pretreated patients with relapsed and refractory multiple myeloma. In the multi-center phase IIb study, ORR was 23.7% with median DOR of 7.8 months.
Researchers at the University of York are launching a major study to improve survival rates for myeloma and lymphoma patients through earlier diagnosis. The study aims to develop an evidence base that could reduce time-to-diagnosis in patients with these cancers, ultimately saving thousands of lives.
A meta-analysis of 10 studies found that cognitive behavioral therapy and pharmacologic interventions decrease depressive symptoms in cancer patients. The study also identified effective interventions for different stages of cancer and cultural subpopulations.
A new study by Oregon State University researchers found that people with physical health problems are three times more likely to seek mental health care. The study highlights the need for better-coordinated care between physical and mental health providers.
New research reveals that adolescents and young adult cancer patients often lack access to the necessary psychological, social support, and information resources. Studies found significant proportions of patients in this age group report unmet needs for mental health services, camp programs, and age-appropriate online resources.
A new epidemiological study found that over 80% of white patients received radiation treatment combined with chemotherapy to preserve the voice box, while only 74.5% of African American patients received the same treatment. The disparity may be narrowing, but further research is needed to identify root causes.
A study found racial disparities in larynx preservation therapy for cancer, with black patients having lower rates of treatment compared to white patients. The use of radiation with chemotherapy as initial treatment has become more widespread, but disparities persist among black patients with stage IV disease.
A new study found that screening intervals between one and three years have similar outcomes for gastric cancer stages, but longer intervals lead to more advanced cancer at diagnosis. The researchers recommend a screening interval of every three years in high-risk regions.
A recent study found that patients who received chemotherapy following removal of periampullary cancer experienced improved overall survival compared to those who did not receive chemotherapy. The study also suggested that gemcitabine therapy provided the most significant survival benefit, with a median survival time of 43.1 months.
Researchers at Ohio State University have identified a new mechanism that promotes cancer growth and spread by releasing tiny vesicles containing microRNA, which alter immune cell behavior. The study suggests a new strategy for treating cancer and diseases of the immune system.
Patients who use interactive personal health records are nearly twice as likely to be up-to-date with recommended preventive services. The study found significant increases in delivery of colorectal, breast, and cervical cancer screenings among IPHR users.
Researchers at Brown University have discovered a way to determine unique leukocyte mixes from blood samples using DNA methylation. The technique can distinguish between various types of cancer and non-cancer conditions, offering a powerful tool for medical research and clinical diagnosis.
A study found that avoiding hospitalizations, worrying less, and having a therapeutic alliance with physicians can improve quality of life for cancer patients at the end of life. The study identified nine factors that explained the most variance in patients' quality of life, including intensive care stays and pastoral care.
Researchers at Ohio State University found that the loss of microRNA-125b (miR-125b) shuts down normal cell metabolism and enables cancer cells to proliferate. The study reveals a new mechanism by which chronic lymphocytic leukemia (CLL) develops, providing potential targets for new drugs.
The Center for Cancer Support and Education in Arlington, Mass., will receive a $10,000 grant from ASTRO's Survivor Circle program to fund breast cancer, advanced cancer, and brain cancer support groups. The Center offers emotional support during treatment and recovery for patients and their family members.
The American Society for Radiation Oncology (ASTRO) has partnered with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to promote cancer survivorship. Through the Survivor Circle exhibit, ASTRO is providing financial assistance and resources to young adult survivors.
A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without radiation or intensive chemotherapy, maintaining excellent long-term survival. The study's findings suggest that patients with favorable-risk disease may benefit from minimal treatment approaches.
A study by the University of Kentucky Markey Cancer Center found that cancer patients experienced significant improvements in pain, stress, and nausea after one Jin Shin Jyutsu session. The study included 159 patients who reported a mean decrease of three points for stress and two points for both pain and nausea.
A recent study published in the Journal of Biological Chemistry reveals that mutant p53 protein aggregates may lead to prion-like behavior, impairing its ability to suppress tumor growth. The findings suggest that this misfolding mechanism could serve as a potential target for cancer therapy.
A new experimental medication called enobosarm safely increases muscle strength and physical functioning among cancer patients with low testosterone levels. In a multi-center trial, enobosarm significantly improved physical function by 19% in men with low testosterone and by 13% in those with normal hormone levels.
Researchers found significant improvements in memory and thinking among cancer patients treated with GMCSF plus GCSF compared to those receiving GCSF alone. The study suggests that GMCSF may prevent or reverse cognitive decline in cancer patients, in addition to Alzheimer's patients.
A new study published in Brain found that multiple sclerosis patients have a lower overall cancer risk, with significant reductions in colorectal cancer risk. While brain and bladder cancer risks were slightly elevated, MS patients with relapsing-onset disease had higher non-melanoma skin cancer risk.
Researchers found that cancers with disorganized traffic systems result in lower survival rates and are more difficult to treat. A mathematical equation could help doctors determine the best course of treatment by identifying the complexity of each cancer type.
A novel family of experimental agents targeting the transport protein CRM1 may offer a new treatment for acute leukemia. The agents, called KPT-SINEs, have been shown to inhibit leukemia-cell proliferation, arrest cell division, and induce cell death and differentiation in animal models.